{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:37:38Z","timestamp":1768275458443,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4286,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.fertnstert.2009.05.044","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T04:45:24Z","timestamp":1247201124000},"page":"1417-1425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study"],"prefix":"10.1016","volume":"94","author":[{"given":"Cesare","family":"Battaglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvia","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Persico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Busacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Venturoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.05.044_bib1","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1210\/jc.2005-0011","article-title":"Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease","volume":"90","author":"Meyer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib3","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"WHO collaborative study of cardiovascular disease and steroid hormone contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study","volume":"349","author":"World Health Organization","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0010-7824(02)00537-1","article-title":"Randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism","volume":"67","author":"Gaspard","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/TCRM.S1964","article-title":"Review of the combined contraceptive vaginal ring NuvaRing\u00ae","volume":"4","author":"Roumen","year":"2008","journal-title":"Therap and Clinic Risk Manag"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30\u03bcg of ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophisiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.AOG.0000296657.41236.10","article-title":"Vascular risk in young women with polycystic ovary and polycystic ovary syndrome","volume":"111","author":"Battaglia","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0002-9378(95)90094-2","article-title":"The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome","volume":"172","author":"Battaglia","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1469-0705.1998.11050332.x","article-title":"Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations","volume":"11","author":"Battaglia","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1971","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1469-0705.1995.05060406.x","article-title":"Circadian variation in uterine artery blood flow indices during the follicular phase of the menstrual cycle","volume":"5","author":"Zaidi","year":"1995","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib15","doi-asserted-by":"crossref","first-page":"H2720","DOI":"10.1152\/ajpheart.2000.279.6.H2720","article-title":"Diurnal variation of flow-mediated vasodilation in healthy premenopausal women","volume":"279","author":"Ringqvist","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.HYP.26.6.912","article-title":"the Participants in the Fourth International Consensus Conference on the 24-Hour Ambulatory Blood Pressure Monitoring. A consensus view on the technique of ambulatory blood pressure monitoring","volume":"26","author":"Staessen","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1373\/clinchem.2004.031757","article-title":"Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes","volume":"50","author":"Tan","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib18","first-page":"22","article-title":"Effects of transdermal glyceryltrinitrate on 24-h blood pressure changes in patients with gestational hypertension","volume":"2","author":"Facchinetti","year":"1997","journal-title":"Prenat Neonat Med"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/humrep\/17.3.659","article-title":"Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study","volume":"17","author":"Battaglia","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib20","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2337\/diab.38.12.1630","article-title":"Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Results from two national samples","volume":"38","author":"Modan","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone: a novel progestogen with antimineralcorticoid and antiandrogenic activity: pharmacological characterization in animal models","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1046\/j.1469-0705.1998.12030180.x","article-title":"Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome","volume":"12","author":"Battaglia","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib23","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib24","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pill","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib25","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydratemetabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl JMed"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1783\/1471189041261636","article-title":"An observational study of Yasmin \u00ae in the management of women with polycystic ovary syndrome","volume":"30","author":"Palep-Singh","year":"2004","journal-title":"J Fam Plan Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib27","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study","volume":"55","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.1999.00701.x","article-title":"The natural history of the metabolic syndrome in young women with polycystic ovary syndrome and the effect of long-term oestrogen-progestogen treatment","volume":"50","author":"Pasquali","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptive (COC) versus COC alone on insulin sensitivity, hyperandrogenemia, SHBG, and lipids in PCOS patients","volume":"20","author":"Cibula","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib30","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1210\/jc.2003-030328","article-title":"Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptive containing cyproterone acetate or desogestrel","volume":"88","author":"Cagnacci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib31","first-page":"3074","article-title":"The effect of desogestrel-containing oral contraceptives on glucose tolerance and leptin concentrations in hyperandrogenic women","volume":"82","author":"Nader","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib32","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.atherosclerosis.2007.03.002","article-title":"The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome","volume":"196","author":"Charitidou","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13697130500330341","article-title":"Drospirenone in combination with estrogens: for contraception and hormone replacement therapy","volume":"8","author":"Oelkers","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.CIR.79.1.93","article-title":"Flow-mediated and reflex changes in large peripheral artery tone in humans","volume":"79","author":"Anderson","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib35","first-page":"889","article-title":"Decreased nitric oxide in women with essential hypertension in prehypertensive phase","volume":"46","author":"Gerasimovska-Kitanovska","year":"2005","journal-title":"Croat Med J"},{"key":"10.1016\/j.fertnstert.2009.05.044_bib36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2004-0745","article-title":"Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects","volume":"90","author":"Kashyap","year":"2005","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209011984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209011984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:44:31Z","timestamp":1758008671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209011984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0015028209011984"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.05.044","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.05.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}